Center of Natural and Human Sciences, Universidade Federal do ABC, Santo André, SP, Brazil.
Brazilian Nanotechnology National Laboratory (LNNano), Brazilian Center for Research in Energy and Materials (CNPEM), 13083-970, Campinas, São Paulo, Brazil.
Carbohydr Polym. 2018 Feb 1;181:514-527. doi: 10.1016/j.carbpol.2017.12.014. Epub 2017 Dec 7.
Cellulose nanocrystals (CNCs) are crystalline nanoparticles that present myriad applications. CNCs are produced from a variety of renewable sources, and they can be chemically modified. Although there are promising perspectives for introducing CNCs into pharmaceutical formulations, prior to achieving commercial products the influence of many parameters such as extraction and toxicity of the resulting products must be revealed. Since there is great physicochemical flexibility in the steps of obtaining and conjugating CNCs, there are uncountable and complex outcomes from the interactions of those parameters. We present a discussion that helps to unveil the whole panorama on the use of CNCs as drug delivery systems. The methods of producing CNCs are correlated to the resulting nanotoxicity from the cellular to organism level. This review points to relevant concerns that must be overcome to attain safe use of these nanostructures. We also discuss the patents and commercially available products based on CNCs.
纤维素纳米晶体(CNCs)是呈结晶状的纳米颗粒,具有多种应用。CNCs 可由多种可再生资源制成,并且可以进行化学修饰。尽管将 CNCs 引入药物制剂具有广阔的前景,但在实现商业化产品之前,必须揭示许多参数的影响,例如提取和毒性。由于获得和结合 CNCs 的步骤具有很大的物理化学灵活性,因此这些参数的相互作用会产生无数复杂的结果。我们提出了一个讨论,有助于揭示将 CNCs 用作药物传递系统的全貌。生产 CNCs 的方法与从细胞到生物体水平的纳米毒性有关。这篇综述指出了必须克服的相关问题,以实现这些纳米结构的安全使用。我们还讨论了基于 CNCs 的专利和市售产品。